1. Home
  2. RENE vs TSVT Comparison

RENE vs TSVT Comparison

Compare RENE & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RENE
  • TSVT
  • Stock Information
  • Founded
  • RENE 2021
  • TSVT 2021
  • Country
  • RENE United States
  • TSVT United States
  • Employees
  • RENE N/A
  • TSVT N/A
  • Industry
  • RENE Blank Checks
  • TSVT Biotechnology: Pharmaceutical Preparations
  • Sector
  • RENE Finance
  • TSVT Health Care
  • Exchange
  • RENE Nasdaq
  • TSVT Nasdaq
  • Market Cap
  • RENE 151.4M
  • TSVT 160.4M
  • IPO Year
  • RENE 2022
  • TSVT N/A
  • Fundamental
  • Price
  • RENE $11.66
  • TSVT $3.07
  • Analyst Decision
  • RENE
  • TSVT Buy
  • Analyst Count
  • RENE 0
  • TSVT 6
  • Target Price
  • RENE N/A
  • TSVT $10.40
  • AVG Volume (30 Days)
  • RENE 3.4K
  • TSVT 270.9K
  • Earning Date
  • RENE 01-01-0001
  • TSVT 11-12-2024
  • Dividend Yield
  • RENE N/A
  • TSVT N/A
  • EPS Growth
  • RENE 42.92
  • TSVT N/A
  • EPS
  • RENE 0.43
  • TSVT N/A
  • Revenue
  • RENE N/A
  • TSVT $45,620,000.00
  • Revenue This Year
  • RENE N/A
  • TSVT N/A
  • Revenue Next Year
  • RENE N/A
  • TSVT $36.09
  • P/E Ratio
  • RENE $26.86
  • TSVT N/A
  • Revenue Growth
  • RENE N/A
  • TSVT N/A
  • 52 Week Low
  • RENE $10.93
  • TSVT $2.78
  • 52 Week High
  • RENE $11.67
  • TSVT $6.40
  • Technical
  • Relative Strength Index (RSI)
  • RENE 63.75
  • TSVT 32.27
  • Support Level
  • RENE $11.64
  • TSVT $2.78
  • Resistance Level
  • RENE $11.65
  • TSVT $4.07
  • Average True Range (ATR)
  • RENE 0.00
  • TSVT 0.24
  • MACD
  • RENE -0.00
  • TSVT -0.05
  • Stochastic Oscillator
  • RENE 87.50
  • TSVT 12.02

About RENE Cartesian Growth Corporation II

Cartesian Growth Corp II is a blank check company.

About TSVT 2seventy bio Inc.

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

Share on Social Networks: